High-Risk Metabolic/Liver Screening Panel
Dr Trivedi's expanded lab workup for patients deemed high risk of metabolic dysfunction, going beyond standard A1C to catch insulin resistance and cardiovascular risk years earlier.
Assembled by Cited from Hirsh Trivedi's recorded recommendations across multiple sources. It is not an ordered program and was not created or endorsed by them — it's our grouping of what they've said on the record.
Components
5-
In a protocol
Check fasting insulin (with fasting glucose for HOMA-IR) in addition to A1C to detect evolving insulin resistance years before diabetes onset.
“I check fasting insulin, I check homa, IR calculation
TP▶ 19:00DosageFasting insulin + fasting glucose; calculate HOMA-IRCertaintyexplicitstrong endorsementFasting insulin paired with fasting glucose -
In a protocol
Use HOMA-IR to quantify insulin resistance from fasting glucose and insulin.
“do a homa IR calculation
TP▶ 19:00CertaintyexplicitrecommendationHOMA-IR calculated from fasting insulin + glucose -
In a protocol
Check Lp(a) as part of an expanded lipid panel in high-risk patients.
“the expanded lipid panel that I call like lp, I'll check as well
TP▶ 19:00CertaintyexplicitrecommendationLp(a) as part of expanded lipid panel -
In a protocol
Use the FIB-4 calculator (from a standard blood panel) to estimate liver fibrosis risk; scores above 1.3 warrant further evaluation.
“if you have a fib 4 score less than 1.3, then those patients are low risk
TP▶ 20:00DosageFIB-4 < 1.3 = low risk; > 1.3 needs specialist referralCaveatsHas limitations; interpret carefullyCertaintyexplicitrecommendationFIB-4 for liver fibrosis risk stratification